4.1 Review

Decellularization technology in CNS tissue repair

期刊

EXPERT REVIEW OF NEUROTHERAPEUTICS
卷 15, 期 5, 页码 493-500

出版社

TAYLOR & FRANCIS LTD
DOI: 10.1586/14737175.2015.1030735

关键词

CNS; decellularization methods; extracellular matrices; stem cell; tissue repair

资金

  1. Scientific Research Foundation of Wenzhou, Zhejiang Province, China [H20090014, Y20090269]
  2. Health Bureau of Zhejiang Province [2010KYB070]
  3. Research Foundation of Education Bureau of Zhejiang Province [Y201009942]
  4. Fresh Talent Program for Science and Technology Wenzhou Medical University [wyx201401011, wyx201401087, wyx201401009, wyx201401085]
  5. Research Funds for Tian Qing Liver Diseases [TQGB20120057]
  6. Project of New Century 551 Talent Nurturing in Wenzhou

向作者/读者索取更多资源

Decellularization methodologies have been successfully used in a variety of tissue engineering and regenerative technologies and methods of decellularization have been developed for target tissues and organs of interest. The technology to promote regeneration and functional recovery in the CNS, including brain and spinal cord, has, however, made slow progress mainly because the intrinsic regenerative potential of the CNS is regarded as low. To date, currently available therapies have been unable to provide significant functional recovery and successful therapies, which could provide functional restoration to the injured brain and spinal cord are controversial. In this review, the authors provide a critical analysis, comparing the advantages and limitations of the major decellularization methods and considering the effects of these methods upon the biologic scaffold material. The authors also review studies that supplement decellularized grafts with exogenous factors, such as stem cells and growth factors, to both promote and enhance regeneration through decellularized allografts.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Nanoscience & Nanotechnology

Laser-Induced Combinatorial Chemotherapeutic, Chemodynamic, and Photothermal Therapy for Hepatocellular Carcinoma Based on Oxaliplatin-Loaded Metal-Organic Frameworks

Run Huang, Weiren Liu, Qinghao Zhang, Guiqi Zhu, Weifeng Qu, Chenyang Tao, Jun Gao, Yuan Fang, Xiutao Fu, Jian Zhou, Yinghong Shi, Jia Fan, Zheng Tang

Summary: In this study, biocompatible MIL-100 nanoparticles were used as an effective vehicle to deliver oxaliplatin for hepatocellular carcinoma treatment. The nanoparticles were coated with polydopamine and NH2-PEGTK-COOH and loaded with oxaliplatin to create a multi-functional system. These nanoparticles are activated in the tumor microenvironment, resulting in the release of oxaliplatin and the generation of cytotoxic reactive oxygen species. Moreover, under near-infrared irradiation, the nanoparticles can generate hyperthermia at tumor sites.

ACS APPLIED MATERIALS & INTERFACES (2023)

Article Gastroenterology & Hepatology

Secondary bile acids improve risk prediction for non-invasive identification of mild liver fibrosis in nonalcoholic fatty liver disease

A-Na Liu, Cui-Fang Xu, Ya-Ru Liu, Dan-Qin Sun, Ling Jiang, Liang-Jie Tang, Pei-Wu Zhu, Sui-Dan Chen, Wen-Yue Liu, Xiao-Dong Wang, Giovanni Targher, Christopher D. D. Byrne, Vincent Wai-Sun Wong, Junfen Fu, Ming-Ming Su, Rohit Loomba, Ming-Hua Zheng, Yan Ni

Summary: This study found that in patients with NAFLD, dysregulated bile acid metabolism was associated with liver fibrosis. Serum levels of secondary bile acids were increased in patients with mild fibrosis, along with other clinical and biochemical abnormalities. Combining serum bile acids with clinical/biochemical biomarkers showed good accuracy in identifying mild fibrosis, but performed less well in identifying significant fibrosis.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Editorial Material Multidisciplinary Sciences

The gut microbiome and nicotine metabolism in NAFLD

Lei Miao, Giovanni Targher, Christopher D. Byrne, Ming-Hua Zheng

SCIENCE BULLETIN (2023)

Article Medicine, General & Internal

Dissecting the multifaceted impact of statin use on fatty liver disease: a multidimensional study

Ibrahim Ayada, Laurens A. van Kleef, Huai Zhang, Kuan Liu, Pengfei Li, Yasir J. Abozaid, Marla Lavrijsen, Harry L. A. Janssen, Luc J. W. van der Laan, Mohsen Ghanbari, Maikel P. Peppelenbosch, Ming-Hua Zheng, Robert J. de Knegt, Qiuwei Pan

Summary: This study comprehensively investigated the potential benefits and mechanism-of-action of statins in relation to non-alcoholic fatty liver disease (NAFLD). The results showed that statin use was associated with a lower prevalence of NASH and fibrosis and might prevent NAFLD. This may be due to the anti-lipid and anti-inflammatory characteristics of statins.

EBIOMEDICINE (2023)

Article Medicine, General & Internal

Hepatocyte apoptosis fragment product cytokeratin-18 M30 level and non-alcoholic steatohepatitis risk diagnosis: an international registry study

Huai Zhang, Rafael S. Rios, Jerome Boursier, Rodolphe Anty, Wah-Kheong Chan, Jacob George, Yusuf Yilmaz, Vincent Wai-Sun Wong, Jiangao Fan, Jean-Francois Dufour, George Papatheodoridis, Li Chen, Joern M. Schattenberg, Junping Shi, Liang Xu, Grace Lai-Hung Wong, Naomi F. Lange, Margarita Papatheodoridi, Yuqiang Mi, Yujie Zhou, Christopher D. Byrne, Giovanni Targher, Gong Feng, Minghua Zheng

Summary: This study aimed to investigate the utility of cytokeratin-18 (CK-18) M30 concentrations as a non-invasive diagnostic tool for non-alcoholic steatohepatitis (NASH). The results showed that there was a difference in CK-18 M30 levels between NASH and non-alcoholic fatty liver (NAFL) patients, but the sensitivity and positive predictive value were not ideal. Therefore, measurement of CK-18 M30 levels alone has limited value for non-invasively diagnosing NASH.

CHINESE MEDICAL JOURNAL (2023)

Article Gastroenterology & Hepatology

Validation of the Blood Test MACK-3 for the Noninvasive Diagnosis of Fibrotic Nonalcoholic Steatohepatitis: An International Study With 1924 Patients

Clemence M. Canivet, Ming-Hua Zheng, Sami Qadri, Luisa Vonghia, Kee-Huat Chuah, Charlotte Costentin, Jacob George, Angelo Armandi, Leon A. Adams, Naomi F. Lange, Odile Blanchet, Valerie Moal, Ramy Younes, Marine Roux, Wah-Kheong Chan, Nathalie Sturm, Mohammed Eslam, Elisabetta Bugianesi, Zhengyi Wang, Jean-Francois Dufour, Sven Francque, Hannele Yki-Jaervinen, Kenneth I. Zheng, Jerome Boursier

Summary: The blood test MACK-3 is an accurate tool to improve patient selection in NASH therapeutic trials.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients

Rong Fan, Guanlin Li, Ning Yu, Xiujuan Chang, Tamoore Arshad, Wen-Yue Liu, Yan Chen, Grace Lai-Hung Wong, Yiyue Jiang, Xieer Liang, Yongpeng Chen, Xiao-Zhi Jin, Zheng Dong, Howard Ho-Wai Leung, Xiao-Dong Wang, Zhen Zeng, Terry Cheuk-Fung Yip, Qing Xie, Deming Tan, Shaoli You, Dong Ji, Jun Zhao, Arun J. Sanyal, Jian Sun, Ming-Hu Zheng, Vincent Wai-Sun Wong, Yongping Yang, Jinlin Hou

Summary: This study evaluated the performance of the aMAP score in diagnosing fibrosis in patients with chronic hepatitis B (CHB). The results showed that the aMAP score had higher accuracy in diagnosing cirrhosis and advanced fibrosis compared to other markers. The combination of aMAP and LSM further improved the accuracy in detecting cirrhosis and advanced fibrosis. The aMAP-LSM model had satisfactory performance in diagnosing fibrosis stage for treated CHB patients, especially those with a significant decrease in LSM after treatment.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Noninvasive assessment of liver disease severity in patients with nonalcoholic fatty liver disease (NAFLD) and type 2 diabetes

Grazia Pennisi, Marco Enea, Vincenzo Falco, Guruprasad P. Aithal, Naaventhan Palaniyappan, Yusuf Yilmaz, Jerome Boursier, Christophe Cassinotto, Victor de Ledinghen, Wah Kheong Chan, Sanjiv Mahadeva, Peter Eddowes, Philip Newsome, Thomas Karlas, Johannes Wiegand, Vincent Wai-Sun Wong, Joern M. Schattenberg, Christian Labenz, Won Kim, Myoung Seok Lee, Monica Lupsor-Platon, Jeremy F. L. Cobbold, Jian-Gao Fan, Feng Shen, Katharina Staufer, Michael Trauner, Rudolf Stauber, Atsushi Nakajima, Masato Yoneda, Elisabetta Bugianesi, Ramy Younes, Silvia Gaia, Ming-Hua Zheng, Calogero Camma, Quentin M. Anstee, Ferenc E. Mozes, Michael Pavlides, Salvatore Petta

Summary: This study evaluated the diagnostic accuracy of simple, noninvasive tests (NITs) in patients with non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes (T2D). The results showed that liver stiffness measurement (LSM) and AGILE 3+ were better at determining advanced fibrosis compared to serum tests. The evaluation of diagnostic methods for NAFLD with T2D is clinically significant.

HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

An international multidisciplinary consensus statement on MAFLD and the risk of CVD

Xiao-Dong Zhou, Giovanni Targher, Christopher D. Byrne, Virend Somers, Seung Up Kim, C. Anwar A. Chahal, Vincent Wai-Sun Wong, Jingjing Cai, Michael D. Shapiro, Mohammed Eslam, Philippe Gabriel Steg, Ki-Chul Sung, Anoop Misra, Jian-Jun Li, Carlos Brotons, Yuli Huang, George V. Papatheodoridis, Aijun Sun, Yusuf Yilmaz, Wah Kheong Chan, Hui Huang, Nahum Mendez-Sanchez, Saleh A. Alqahtani, Helena Cortez-Pinto, Gregory Y. H. Lip, Robert J. de Knegt, Ponsiano Ocama, Manuel Romero-Gomez, Marat Fudim, Giada Sebastiani, Jang Won Son, John D. Ryan, Ignatios Ikonomidis, Sombat Treeprasertsuk, Daniele Pastori, Monica Lupsor-Platon, Herbert Tilg, Hasmik Ghazinyan, Jerome Boursier, Masahide Hamaguchi, Mindie H. Nguyen, Jian-Gao Fan, George Boon-Bee Goh, Mamun Al Mahtab, Saeed Hamid, Nilanka Perera, Jacob George, Ming-Hua Zheng

Summary: Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is closely linked to cardiovascular disease (CVD), but the CVD risk is often underestimated. An international panel of experts conducted a Delphi survey to establish the association between MAFLD and CVD risk, and identified potential areas for future research.

HEPATOLOGY INTERNATIONAL (2023)

Article Cell Biology

CD36+ cancer-associated fibroblasts provide immunosuppressive microenvironment for hepatocellular carcinoma via secretion of macrophage migration inhibitory factor

Gui-Qi Zhu, Zheng Tang, Run Huang, Wei-Feng Qu, Yuan Fang, Rui Yang, Chen-Yang Tao, Jun Gao, Xiao-Ling Wu, Hai-Xiang Sun, Yu-Fu Zhou, Shu-Shu Song, Zhen-Bin Ding, Zhi Dai, Jian Zhou, Dan Ye, Duo-Jiao Wu, Wei-Ren Liu, Jia Fan, Ying-Hong Shi

Summary: Hepatocellular carcinoma (HCC) is a type of cancer that is resistant to immunotherapy due to its high cellular heterogeneity. The heterogeneity of cancer-associated fibroblast (CAF) in HCC tumors was identified through single cell RNA sequencing. CD36(+) CAFs were found to have high-level lipid metabolism and expression of macrophage migration inhibitory factor (MIF). These cells were derived from hepatic stellate cells. CD36 mediated the expression of MIF through oxidized LDL uptake and activated the lipid peroxidation/p38/CEBPs axis in CD36(+) CAFs, which recruited myeloid-derived suppressor cells (MDSCs) in a MIF- and CD74-dependent manner. Co-implantation of CD36(+) CAFs with HCC cells promoted HCC progression in vivo. Furthermore, a CD36 inhibitor was shown to enhance the effect of anti-PD-1 immunotherapy by restoring antitumor T-cell responses in HCC.

CELL DISCOVERY (2023)

Article Gastroenterology & Hepatology

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

Ferenc E. Mozes, Jenny A. Lee, Yasaman Vali, Osama Alzoubi, Katharina Staufer, Michael Trauner, Rafael Paternostro, Rudolf E. Stauber, Adriaan G. Holleboom, Anne-Marieke van Dijk, Anne Linde Mak, Jerome Boursier, Marc de Saint Loup, Toshihide Shima, Elisabetta Bugianesi, Silvia Gaia, Angelo Armandi, Shalimar, Monica Lupsor-Platon, Vincent Wai-Sun Wong, Guanlin Li, Grace Lai-Hung Wong, Jeremy Cobbold, Thomas Karlas, Johannes Wiegand, Giada Sebastiani, Emmanuel Tsochatzis, Antonio Liguori, Masato Yoneda, Atsushi Nakajima, Hannes Hagstrom, Camilla Akbari, Masashi Hirooka, Wah-Kheong Chan, Sanjiv Mahadeva, Ruveena Rajaram, Ming-Hua Zheng, Jacob George, Mohammed Eslam, Salvatore Petta, Grazia Pennisi, Mauro Vigano, Sofia Ridolfo, Guruprasad Padur Aithal, Naaventhan Palaniyappan, Dae Ho Lee, Mattias Ekstedt, Patrik Nasr, Christophe Cassinotto, Victor de Ledinghen, Annalisa Berzigotti, Yuly P. Mendoza, Mazen Noureddin, Emily Truong, Celine Fournier-Poizat, Andreas Geier, Miljen Martic, Theresa Tuthill, Quentin M. Anstee, Stephen A. Harrison, Patrick M. Bossuyt, Michael Pavlides

Summary: Non-invasive tests show comparable prognostic performance to histologically assessed fibrosis in predicting clinical outcomes in NAFLD patients, suggesting they could be considered as alternatives to liver biopsy.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Development and validation of nonalcoholic fatty liver disease test: a simple sensitive and specific marker for early diagnosis of nonalcoholic fatty liver disease

Mohamed Omran, Mona Omr, Amal A. Mohamed, Reem A. Abdelghafour, Nashwa M. Muharram, Mohamed B. Hassan, Abobakrelsedik Fangry, Tarek Emran, Juan P. Arab, Jorge Arnold, Luis Antonio Diaz, Ming-Hua Zheng, Mohamed El-Kassas

Summary: The aim of this study was to develop a noninvasive test for identifying patients with NAFLD based on clinical and routine laboratory data. Elevated CRP, cholesterol, BMI, and ALT levels were significantly associated with NAFLD. The developed NAFLD test showed high diagnostic performance with an AUC of 0.92 and was validated in patients from Egypt, China, and Chile.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

LEARN algorithm: a novel option for predicting non-alcoholic steatohepatitis

Gang Li, Tian-Lei Zheng, Xiao-Ling Chi, Yong-Fen Zhu, Jin-Jun Chen, Liang Xu, Jun-Ping Shi, Xiao-Dong Wang, Wei-Guo Zhao, Christopher D. Byrne, Giovanni Targher, Rafael S. Rios, Ou-Yang Huang, Liang-Jie Tang, Shi-Jin Zhang, Shi Geng, Huan-Ming Xiao, Sui-Dan Chen, Rui Zhang, Ming-Hua Zheng

Summary: The study developed a deep neural network algorithm (LEARN) based on impedance-based measurements of body composition, which can identify non-alcoholic steatohepatitis (NASH) with good discriminatory ability in the validation group.

HEPATOBILIARY SURGERY AND NUTRITION (2023)

Letter Gastroenterology & Hepatology

Microbial-host-isozyme: unveiling a new era in microbiome-host interaction

Lei Miao, Herbert Tilg, Ming-Hua Zheng

Summary: Wang K. et al. introduced the concept of Microbial-Host isozymes (MHIs) and emphasized their role in mediating microbiota-host interactions. They discovered bacterial-derived DPP4 as an isoenzyme that affects glucose tolerance and demonstrated that host DPP4 inhibitors may not effectively target bacterial DPP4. By developing an MHI screen system, they identified 71 MHIs in healthy gut microbiota, among which DPP4 isozymes degrade GLP-1, explaining the variable responses to sitagliptin. This breakthrough offers new avenues for the treatment of metabolic disorders, and precise interventions in gut microbiota provide personalized approaches to metabolic diseases.

GUT MICROBES (2023)

Article Gastroenterology & Hepatology

Characterisation of forkhead box protein A3 as a key transcription factor for hepatocyte regeneration

Guoqiang Li, Lijun Zhu, Mingwei Guo, Dongmei Wang, Meiyao Meng, Yinzhao Zhong, Zhijian Zhang, Yi Lin, Caizhi Liu, Jiawen Wang, Yahui Zhang, Yining Gao, Yuxiang Cao, Zhirui Xia, Jin Qiu, Yu Li, Shuang Liu, Haibing Chen, Wenyue Liu, Yu Han, Minghua Zheng, Lingyan Xu, Xinran Ma

Summary: This study demonstrates that Foxa3 is an important regulator of liver regeneration, maintaining normal liver cell proliferation and repair by governing Cebpb transcription. It was found that pharmacological activation of Foxa3 can accelerate hepatocyte proliferation without interfering with the termination of liver regeneration. These findings contribute to a better understanding of the mechanism of liver regeneration and provide a potential therapeutic target for treating liver injury.

JHEP REPORTS (2023)

暂无数据